These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 32032734)
1. Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function. Anand N; Holcom A; Broussalian M; Schmidt M; Chinta SJ; Lithgow GJ; Andersen JK; Chamoli M Neurobiol Dis; 2020 Jun; 139():104786. PubMed ID: 32032734 [TBL] [Abstract][Full Text] [Related]
2. Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease. Rajagopalan S; Rane A; Chinta SJ; Andersen JK J Neurosci; 2016 Jan; 36(4):1086-95. PubMed ID: 26818499 [TBL] [Abstract][Full Text] [Related]
3. ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress. Vrijsen S; Besora-Casals L; van Veen S; Zielich J; Van den Haute C; Hamouda NN; Fischer C; Ghesquière B; Tournev I; Agostinis P; Baekelandt V; Eggermont J; Lambie E; Martin S; Vangheluwe P Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31198-31207. PubMed ID: 33229544 [TBL] [Abstract][Full Text] [Related]
4. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2. Park JS; Sue CM Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689 [TBL] [Abstract][Full Text] [Related]
5. Overlapping expression patterns and functions of three paralogous P5B ATPases in Caenorhabditis elegans. Zielich J; Tzima E; Schröder EA; Jemel F; Conradt B; Lambie EJ PLoS One; 2018; 13(3):e0194451. PubMed ID: 29547664 [TBL] [Abstract][Full Text] [Related]
6. PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Ramonet D; Podhajska A; Stafa K; Sonnay S; Trancikova A; Tsika E; Pletnikova O; Troncoso JC; Glauser L; Moore DJ Hum Mol Genet; 2012 Apr; 21(8):1725-43. PubMed ID: 22186024 [TBL] [Abstract][Full Text] [Related]
7. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9). Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191 [TBL] [Abstract][Full Text] [Related]
8. Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Dehay B; Martinez-Vicente M; Ramirez A; Perier C; Klein C; Vila M; Bezard E Autophagy; 2012 Sep; 8(9):1389-91. PubMed ID: 22885599 [TBL] [Abstract][Full Text] [Related]
9. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function. Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751 [TBL] [Abstract][Full Text] [Related]
10. Loss of ATP13A2 impairs glycolytic function in Kufor-Rakeb syndrome patient-derived cell models. Park JS; Koentjoro B; Davis RL; Sue CM Parkinsonism Relat Disord; 2016 Jun; 27():67-73. PubMed ID: 27039055 [TBL] [Abstract][Full Text] [Related]
11. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. Tan J; Zhang T; Jiang L; Chi J; Hu D; Pan Q; Wang D; Zhang Z J Biol Chem; 2011 Aug; 286(34):29654-62. PubMed ID: 21724849 [TBL] [Abstract][Full Text] [Related]
12. The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis. Marcos AL; Corradi GR; Mazzitelli LR; Casali CI; Fernández Tome MDC; Adamo HP; de Tezanos Pinto F Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182993. PubMed ID: 31132336 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062 [TBL] [Abstract][Full Text] [Related]
15. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay. Kırımtay K; Temizci B; Gültekin M; Yapıcı Z; Karabay A Brain Res; 2021 Jan; 1750():147167. PubMed ID: 33091395 [TBL] [Abstract][Full Text] [Related]
16. Lysosomal Storage of Subunit c of Mitochondrial ATP Synthase in Brain-Specific Atp13a2-Deficient Mice. Sato S; Koike M; Funayama M; Ezaki J; Fukuda T; Ueno T; Uchiyama Y; Hattori N Am J Pathol; 2016 Dec; 186(12):3074-3082. PubMed ID: 27770614 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity. Ugolino J; Dziki KM; Kim A; Wu JJ; Vogel BE; Monteiro MJ PLoS One; 2019; 14(8):e0220849. PubMed ID: 31393918 [TBL] [Abstract][Full Text] [Related]
18. CATP-6, a C. elegans ortholog of ATP13A2 PARK9, positively regulates GEM-1, an SLC16A transporter. Lambie EJ; Tieu PJ; Lebedeva N; Church DL; Conradt B PLoS One; 2013; 8(10):e77202. PubMed ID: 24130856 [TBL] [Abstract][Full Text] [Related]
19. The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity. Rinaldi DE; Corradi GR; Cuesta LM; Adamo HP; de Tezanos Pinto F Biochim Biophys Acta; 2015 Aug; 1848(8):1646-55. PubMed ID: 25912790 [TBL] [Abstract][Full Text] [Related]